"10.1371_journal.pone.0093541","plos one","2014-03-27T00:00:00Z","Junyun He; Huafang Lai; Michael Engle; Sergey Gorlatov; Clemens Gruber; Herta Steinkellner; Michael S Diamond; Qiang Chen","The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America; College of Technology and Innovation, Arizona State University, Mesa, Arizona, United States of America; Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Pathology & Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Chemistry, University of Natural Resources and Applied Life Sciences, Vienna, Austria; Department of Applied Genetics and Cell Biology, University of Natural Resources and Applied Life Sciences, Vienna, Austria; MacroGenics, Inc, Rockville, Maryland, United States of America","Conceived and designed the experiments: QC MD HS JH HL. Performed the experiments: JH HL ME SG CG. Analyzed the data: QC MD HS JH HL ME SG CG. Contributed reagents/materials/analysis tools: QC MD HS JH HL ME SG CG. Wrote the paper: QC MD HS JH HL ME SG CG.","S. Gorlatov is an employee of MacroGenics, Inc, which has licensed the WNV E16 antibody from Washington University for possible commercial development. Additionally, M. Diamond is a paid consultant for MacroGenics and owns equity in MacroGenics. These relationships do not alter the authors adherence to PLOS ONE policies on sharing data and materials. None of the other authors have a potential financial stake or conflict of interest associated with the publication of this work.","2014","03","Junyun He","JH",8,TRUE,5,5,8,8,TRUE,TRUE,FALSE,0,NA,FALSE
